---
title: "Boston Scientific (BSX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BSX.US/norm.md"
symbol: "BSX.US"
name: "Boston Scientific"
parent: "https://longbridge.com/en/quote/BSX.US.md"
datetime: "2026-05-20T14:28:46.646Z"
locales:
  - [en](https://longbridge.com/en/quote/BSX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BSX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BSX.US/norm.md)
---

# Boston Scientific (BSX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.9000 | 0.4501 | 0.5095 | 0.5300 | 0.4500 |
| ROE | 21.41% | 11.29% | 13.18% | 14.29% | 12.26% |
| Revenue | 5.20B | 5.29B | 5.07B | 5.06B | 4.66B |
| Net income | 1.34B | 672.00M | 755.00M | 797.00M | 674.00M |
| Operating income | 1.07B | 1.04B | 1.05B | 943.00M | 937.00M |
| Gross margin | 69.21% | 69.47% | 69.69% | 67.38% | 68.54% |
| Net margin | 25.77% | 12.71% | 14.91% | 15.75% | 14.45% |
| Profit quality | 308.05% | 76.32% | 78.18% | 73.33% | 173.20% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 44.35B | 43.67B | 42.71B | 41.56B | 40.14B |
| Leverage | 1.70 | 1.78 | 1.81 | 1.83 | 1.79 |
| BVPS | 17.40 | 16.34 | 15.78 | 15.14 | 15.02 |
| Turnover | 0.4880 | 0.4833 | 0.4790 | 0.4702 | 0.4571 |
| Cash & STI | 1.45B | 1.97B | 1.27B | 534.00M | 725.00M |
| Inv & Rec | 3.12B | 2.94B | 2.92B | 2.86B | 2.87B |
| LT assets | 4.61B | 4.50B | 4.29B | 3.95B | 3.84B |
| Net debt | 9.58B | 10.01B | 10.77B | 11.49B | 10.98B |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 348.00M | 1.36B | 1.34B | 1.29B | 541.00M |
| Investing CF | -591.00M | -512.00M | -502.00M | -1.13B | -500.00M |
| Financing CF | -260.00M | -184.00M | -104.00M | -340.00M | 233.00M |
| Free CF | 5.00M | 871.63M | 779.25M | 1.22B | 434.63M |
| OCF coverage | 79.82% | 243.57% | 339.14% | 273.04% | 36.11% |
| Repaid & issued | - | 0.0000 | 0.0000 | 0.0000 | 1.56B |
| CapEx | -177.00M | -351.00M | -181.00M | -157.00M | -187.00M |